HCW BIOLOGICS INC (HCWB) Stock Price, Forecast & Analysis
USA - NASDAQ:HCWB - US40423R2040 - Common Stock
HCWB Key Statistics, Chart & Performance
The current stock price of HCWB is 3.87 USD. In the past month the price decreased by -4.21%. In the past year, price decreased by -77.5%.
HCWB Latest News, Press Relases and Analysis
HCWB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 23.07 | 385.18B | ||
| AMGN | AMGEN INC | 13.68 | 160.66B | ||
| GILD | GILEAD SCIENCES INC | 14.63 | 148.64B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.12 | 109.11B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.48 | 69.08B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 350.8 | 59.78B | ||
| ARGX | ARGENX SE - ADR | 61.04 | 50.39B | ||
| INSM | INSMED INC | N/A | 40.08B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.01 | 34.10B | ||
| NTRA | NATERA INC | N/A | 27.30B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.98B | ||
| BIIB | BIOGEN INC | 9.22 | 22.62B |
Related stock screener links
About HCWB
Company Profile
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The company is headquartered in Miramar, Florida and currently employs 36 full-time employees. The company went IPO on 2021-07-20. The company is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. The company has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The firm is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.
Company Info
HCW BIOLOGICS INC
2929 N Commerce Pkwy, Miramar, Fl 33025
Miramar FLORIDA US
Employees: 36
Phone: 19548422024
HCW BIOLOGICS INC / HCWB FAQ
Can you describe the business of HCW BIOLOGICS INC?
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The company is headquartered in Miramar, Florida and currently employs 36 full-time employees. The company went IPO on 2021-07-20. The company is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. The company has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The firm is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.
Can you provide the latest stock price for HCW BIOLOGICS INC?
The current stock price of HCWB is 3.87 USD. The price decreased by -1.02% in the last trading session.
Does HCWB stock pay dividends?
HCWB does not pay a dividend.
What is the ChartMill technical and fundamental rating of HCWB stock?
HCWB has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Would investing in HCW BIOLOGICS INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on HCWB.
What is the market capitalization of HCWB stock?
HCW BIOLOGICS INC (HCWB) has a market capitalization of 8.32M USD. This makes HCWB a Nano Cap stock.
HCWB Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to HCWB. When comparing the yearly performance of all stocks, HCWB is a bad performer in the overall market: 95.42% of all stocks are doing better.
HCWB Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to HCWB. HCWB may be in some trouble as it scores bad on both profitability and health.
HCWB Financial Highlights
Over the last trailing twelve months HCWB reported a non-GAAP Earnings per Share(EPS) of -16.07. The EPS increased by 61.03% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -74.56% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
HCWB Forecast & Estimates
7 analysts have analysed HCWB and the average price target is 35.7 USD. This implies a price increase of 822.48% is expected in the next year compared to the current price of 3.87.
For the next year, analysts expect an EPS growth of 79.82% and a revenue growth -23.55% for HCWB